Proteomics International
Proteomics International Opens US CLIA Laboratory
The company will use the lab to run its PromarkerD proteomic blood test for identifying individuals at risk of diabetes-related chronic kidney disease.
Proteomics International Planning Australia Launch of Endometriosis Test in Q2; US Launch to Follow
Premium
The proteomic blood test could be a noninvasive tool used to improve detection of the condition, which currently takes an average of 7.5 years to diagnose.
In Brief This Week:, Hologic, Revvity, Pillar Biosciences, Mainz Biomed, More
News items for the week of Oct. 21, 2024.
Proteomics International Ends Licensing Deal With Sonic Health for Promarker D Test
The company said the parties had not met certain milestones required for commercialization of the test, which predicts risk of diabetic kidney disease.
In Brief This Week: Agilent Technologies; T2 Biosystems; Genetic Signatures; More
News items for the week of July 29, 2024.